GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human alpha-dystroglycan

Analyse Crystal structure of human alpha-dystroglycan in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5LLK
Type
protein
Length
226 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dystroglycan
UniProt
Q14118
Pockets
1 · best druggability 0.53

Structure

x-ray diffraction · 1 distinct chain · 20% helix, 37% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADystroglycanprotein22620% helix, 37% strandQ14118

Ligands and binding sites

  • EDO · 1,2-ethanediol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12510.530.7628empty

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 5LLK · Crystal structure of human alpha-dystroglycan · the same entry in another collection · chain A against A, TM-score 1.00
  • Q14118 · AlphaFold monomer V2.0 prediction for dystroglycan (Q14118) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.